Literature DB >> 15364613

Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death.

N Lowri Thomas1, Christopher H George, F Anthony Lai.   

Abstract

OBJECTIVES: Point mutations in the cardiac ryanodine receptor (RyR2) mediate abnormal intracellular Ca(2+) release and are associated with stress-induced ventricular tachycardia (VT), leading to sudden cardiac death (SCD). Although the precise molecular basis of RyR2 dysfunction in SCD remains controversial, there is consensus that the mutations characterised to date all exhibit gain-of-function Ca(2+) release properties following cell stimulation. We investigated the functional impact of a distinct set of SCD-linked RyR2 mutations (L(433)P, N(2386)I, R(176)Q/T(2504)M) on intracellular Ca(2+) handling.
METHODS: We expressed full-length recombinant human wild-type (WT) and SCD-linked RyR2 mutations in human embryonic kidney (HEK) cells, and profiled the spatial and amplitude characteristics of caffeine-evoked Ca(2+) release through homo-tetrameric channels in living cells using rapid confocal laser scanning microscopy.
RESULTS: Analysis of the precise mode of Ca(2+) release in HEK cells expressing RyR2 mutants demonstrated profound differences when compared with WT channels. The SCD-linked RyR2 mutations characterised in this study exhibited heterogeneous Ca(2+) release profiles, including the novel observation that one of the mutants, (L(433)P), exhibited a marked reduction in sensitivity to channel activation. However, all SCD-linked RyR2 mutations characterised in this study resulted in an increased duration of elevated cytoplasmic Ca(2+) levels following channel activation.
CONCLUSIONS: Our live cell-based data demonstrates functional heterogeneity of Ca(2+) release through SCD-linked RyR2 mutants, suggesting that the mechanistic basis of RyR2 dysfunction in SCD may be more complex than previously anticipated. These findings may have profound consequences for the therapeutic modulation of RyR2 in stress-induced VT and SCD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364613     DOI: 10.1016/j.cardiores.2004.06.009

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  21 in total

Review 1.  Cardiac and skeletal muscle disorders caused by mutations in the intracellular Ca2+ release channels.

Authors:  Silvia G Priori; Carlo Napolitano
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 2.  The molecular basis of catecholaminergic polymorphic ventricular tachycardia: what are the different hypotheses regarding mechanisms?

Authors:  Xander H T Wehrens
Journal:  Heart Rhythm       Date:  2006-12-15       Impact factor: 6.343

3.  Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy.

Authors:  Prince J Kannankeril; Brett M Mitchell; Sanjeewa A Goonasekera; Mihail G Chelu; Wei Zhang; Subeena Sood; Debra L Kearney; Cristina I Danila; Mariella De Biasi; Xander H T Wehrens; Robia G Pautler; Dan M Roden; George E Taffet; Robert T Dirksen; Mark E Anderson; Susan L Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-27       Impact factor: 11.205

Review 4.  Ryanodine receptor channelopathies.

Authors:  Matthew J Betzenhauser; Andrew R Marks
Journal:  Pflugers Arch       Date:  2010-02-24       Impact factor: 3.657

5.  Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death.

Authors:  Dawei Jiang; Wenqian Chen; Ruiwu Wang; Lin Zhang; S R Wayne Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-01       Impact factor: 11.205

6.  Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Randall Loaiza; Nancy A Benkusky; Patricia P Powers; Timothy Hacker; Sami Noujaim; Michael J Ackerman; José Jalife; Héctor H Valdivia
Journal:  Circ Res       Date:  2012-11-14       Impact factor: 17.367

Review 7.  Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

Authors:  Lynda M Blayney; F Anthony Lai
Journal:  Pharmacol Ther       Date:  2009-04-01       Impact factor: 12.310

8.  Cardiac ryanodine receptors control heart rate and rhythmicity in adult mice.

Authors:  Michael J Bround; Parisa Asghari; Rich B Wambolt; Lubos Bohunek; Claire Smits; Marjolaine Philit; Timothy J Kieffer; Edward G Lakatta; Kenneth R Boheler; Edwin D W Moore; Michael F Allard; James D Johnson
Journal:  Cardiovasc Res       Date:  2012-08-06       Impact factor: 10.787

Review 9.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

10.  Insights into the gating mechanism of the ryanodine-modified human cardiac Ca2+-release channel (ryanodine receptor 2).

Authors:  Saptarshi Mukherjee; N Lowri Thomas; Alan J Williams
Journal:  Mol Pharmacol       Date:  2014-07-07       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.